SCIENTIFIC HUB

Follow the evidence.

15.265 articles found

Source record

Aerobic exercise acutely increases EEG gamma power in the motor/sensorimotor areas during walking in people with Parkinson's disease.

Orcioli-Silva D, Vitório R, Beretta VS, Souza Oliveira A, Conceição NRD, Nóbrega-Sousa P, Santos PCRD, Gobbi LTB, Barela JA.

Clin Neurophysiol · 2025-05-17

DOI: 10.1016/j.clinph.2025.2110755PMID: 40413811

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

AI-DBS study: protocol for a longitudinal prospective observational cohort study of patients with Parkinson's disease for the development of neuronal fingerprints using artificial intelligence.

Stam MJ, de Neeling MGJ, Keulen BJ, Hubers D, de Bie RMA, Schuurman R, Buijink AWG, van Wijk BCM, Beudel M.

BMJ Open · 2025-05-16

DOI: 10.1136/bmjopen-2024-091563PMID: 40379316

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Chemical Profiling of Polyphenolic Fraction of <i>Cannabis sativa</i> L. vr. <i>Kompolti</i> Industrial Inflorescences: Insights into Cannabidiol Neuroprotective Effects in a Cellular Model of Parkinson's Disease.

Fantasma F, D'Urso G, Martella N, Capuano A, Boccia E, Samukha V, De Felice V, Saviano G, Trombetta F, Lauro G, Segatto M, Chini MG, Bifulco G, Casapullo A, Iorizzi M.

Plants (Basel) · 2025-05-14

DOI: 10.3390/plants14101473PMID: 40431038

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Effects and mechanisms of acupuncture for PIGD-subtype Parkinson's disease via integration of fMRI and gut microbiota-metabolomics analysis: protocol for a prospective randomized controlled trial.

Sheng J, Xu Y, Liu T, Zhu J, Mu C, Zhai L, Xu S, Wang H, Liu X, Liu T, Jin X.

Front Aging Neurosci · 2025-05-13

DOI: 10.3389/fnagi.2025.1534165PMID: 40433511

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).

Halbherr S, Lerch S, Bellwald S, Polakova P, Bannert B, Roumet M, Charles RP, Walter MA, Bernasconi C, Halbherr VL, Peitsch C, Baumgartner PC, Kaufmann C, Aires V, Mattle HP, Kaelin-Lang A, Hartmann A, Schuepbach M.

PLoS Med · 2025-05-13

DOI: 10.1371/journal.pmed.1004472PMID: 40359409

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.

Young CB, Cholerton B, Smith AM, Shahid-Besanti M, Abdelnour C, Mormino EC, Hu SC, Chung KA, Peterson A, Rosenthal L, Pantelyat A, Dawson TM, Quinn J, Zabetian CP, Montine TJ, Poston KL.

Neurology · 2025-05-12

DOI: 10.1212/wnl.0000000000213648PMID: 40354588

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.